Their story
L2D was founded in 2009 by three experienced drug developers who had worked together managing the development of the product pipeline of a French biotech. They realised there would be a massive value for biotechs to outsource the operational management of their preclinical development rather than bringing in in-house expertise that would often only be needed for a finite period. The company was immediately accepted by the prestigious Paris-Biotech Santé incubator and rapidly found its first clients.
Since then, L2D has steadily grown and has moved twice to larger offices. The team has not only expanded, but the types of services offered have been extended to include all non-clinical aspects of drug development, injectable medical device development and the over-sight of clinical trials.